Tempus AI

Tempus AITempus AI
Tempus AI

Tempus AI

AI-enabled precision medicine platform using clinical and molecular data to improve patient outcomes.

DR 722015ActiveChicago, United States
Rate

About

Tempus is an AI-powered precision medicine company that analyzes clinical and molecular data to accelerate research and improve patient care. Its platform offers genomic testing, AI-enabled algorithms, and real-world data solutions to support providers in making informed treatment decisions, life sciences companies in drug development, and patients in accessing clinical trials. Tempus serves physicians, researchers, life sciences organizations, and patients across oncology, neurology, psychiatry, cardiology, and radiology.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Tempus AI do?

Tempus is an AI-powered precision medicine company that analyzes clinical and molecular data to accelerate research and improve patient care. Its platform offers genomic testing, AI-enabled algorithms, and real-world data solutions to support providers in making informed treatment decisions, life sciences companies in drug development, and patients in accessing clinical trials. Tempus serves physicians, researchers, life sciences organizations, and patients across oncology, neurology, psychiatry…

How much funding has Tempus AI raised?

Tempus AI has raised a total of $380M in funding. The most recent round on record is Series F.

Where is Tempus AI headquartered?

Tempus AI is headquartered in Chicago, United States.

When was Tempus AI founded?

Tempus AI was founded in 2015.

What industry does Tempus AI operate in?

Tempus AI operates in AI, Healthcare, Biotech, Precision Medicine.

What is Tempus AI's revenue?

StartupHub estimates Tempus AI's annual revenue at $584.9M (range $259.4M to $1.1B, 47% confidence), based on comparable companies in the sector.

What is Tempus AI's valuation?

StartupHub estimates Tempus AI's effective valuation at $3.1B (range $1.5B to $7.0B, 45% confidence), based on comparable companies in the sector.